Literature DB >> 2875472

Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses.

M A Geyer, P V Russo, V L Masten.   

Abstract

A Behavioral Pattern Monitor (BPM) is described which is designed to assess the spatial and temporal sequences of the locomotor movements, investigatory holepokes, and rearings of rats. The system records these behavioral responses with 0.1 sec resolution in time and 1.5 inch resolution in space, and permanently stores all the resulting data. The sequences of these responses may then be displayed on a video terminal or on paper and are also available for the calculation of a variety of descriptive statistics. Studies are described in which rats were tested repeatedly without any pharmacological treatments or in single test sessions following the administration of saline or one of five stimulant drugs. A variety of descriptive measures of the temporal or spatial patterning of the animals' behavior are described and applied to the data resulting from the studies of the various stimulants. It is concluded that the combination of these measures enables distinctions to be made among these drugs which cannot be made on the basis of measures of the amount of locomotor activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2875472     DOI: 10.1016/0091-3057(86)90266-2

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  79 in total

1.  Somatostatin-28 modulates prepulse inhibition of the acoustic startle response, reward processes and spontaneous locomotor activity in rats.

Authors:  Svetlana Semenova; Daniel Hoyer; Mark A Geyer; Athina Markou
Journal:  Neuropeptides       Date:  2010-10       Impact factor: 3.286

Review 2.  Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies.

Authors:  Jordy van Enkhuizen; Mark A Geyer; Arpi Minassian; William Perry; Brook L Henry; Jared W Young
Journal:  Neurosci Biobehav Rev       Date:  2015-08-19       Impact factor: 8.989

Review 3.  Animal models of bipolar mania: The past, present and future.

Authors:  R W Logan; C A McClung
Journal:  Neuroscience       Date:  2015-08-24       Impact factor: 3.590

4.  Quantifying over-activity in bipolar and schizophrenia patients in a human open field paradigm.

Authors:  William Perry; Arpi Minassian; Brook Henry; Meegin Kincaid; Jared W Young; Mark A Geyer
Journal:  Psychiatry Res       Date:  2010-05-14       Impact factor: 3.222

5.  Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities.

Authors:  H Sago; E J Carlson; D J Smith; J Kilbridge; E M Rubin; W C Mobley; C J Epstein; T T Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

6.  Suppression of behavioral activity by norfenfluramine and related drugs in rats is not mediated by serotonin release.

Authors:  C W Callaway; L L Wing; D E Nichols; M A Geyer
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Dopamine depletion attenuates some behavioral abnormalities in a hyperdopaminergic mouse model of bipolar disorder.

Authors:  Jordy van Enkhuizen; Mark A Geyer; Adam L Halberstadt; Xiaoxi Zhuang; Jared W Young
Journal:  J Affect Disord       Date:  2013-11-16       Impact factor: 4.839

8.  The interoceptive Pavlovian stimulus effects of caffeine.

Authors:  Jennifer E Murray; Chia Li; Matthew I Palmatier; Rick A Bevins
Journal:  Pharmacol Biochem Behav       Date:  2007-04-03       Impact factor: 3.533

9.  Functional behavioral homology between rat 5-HT1B and guinea pig 5-HT1D receptors in the modulation of prepulse inhibition of startle.

Authors:  T E Sipes; M A Geyer
Journal:  Psychopharmacology (Berl)       Date:  1996-06       Impact factor: 4.530

10.  5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice.

Authors:  Adam L Halberstadt; Iris van der Heijden; Michael A Ruderman; Victoria B Risbrough; Jay A Gingrich; Mark A Geyer; Susan B Powell
Journal:  Neuropsychopharmacology       Date:  2009-03-25       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.